Literature DB >> 10819243

Very low density lipoprotein subfractions in Type II diabetes mellitus: alterations in composition and susceptibility to oxidation.

J McEneny1, M J O'Kane, K W Moles, C McMaster, D McMaster, C Mercer, E R Trimble, I S Young.   

Abstract

AIMS/HYPOTHESIS: Type II (non-insulin-dependent) diabetes mellitus is associated with raised triglycerides and increased very low density lipoprotein cholesterol. The aim of this study was to assess if very low density lipoprotein subfraction composition and potential to oxidise were altered in this condition.
METHODS: Very low density lipoprotein was separated into four subfractions (A-->D) by a novel, rapid ultracentrifugation procedure. Analysis of each subfraction included lipid and fatty acid composition. Preformed peroxides were measured spectrophotometrically and conjugated dienes were used as an indicator of in vitro lipid oxidation.
RESULTS: In all results we compared patient and control subfractions. Mean fasting plasma glucose was 8.9 +/- 2.0 mmol/l in patients vs 5.1 +/- 0.4 mmol/l in control subjects (p < 0.001); patient HbA1c was 7.6 +/- 1.4%. Patient total lipid standardised for apo B was higher than controls in subfractions A, B and C; A, 201 vs 60; B, 191 vs 40; C, 63 vs 21; D, 29 vs 34 micromol lipid per mg apo B (p < 0.05). Preformed peroxides were higher in all patient subfractions compared with controls: A, 340 vs 48; B, 346 vs 42; C, 262 vs 28; D, 54 vs 16 nmol per mg apo B (p < 0.001). Patient subfractions A and D were more susceptible to in vitro oxidation. Monounsaturated fatty acids were lower in patients subfractions, 35.2 vs 36.7; B, 35.1 vs 38.7; C, 34.4 vs 36.5; D, 33.0 vs 35.5 as per cent total (p < 0.05). CONCLUSIONS/
INTERPRETATION: These results indicate abnormalities in very low density lipoprotein subfraction composition and oxidation profile in Type II diabetic subjects, which are characteristic of more atherogenic particles and that may contribute to the development of cardiovascular disease in these patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10819243     DOI: 10.1007/s001250051333

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  13 in total

1.  Reducing oxidized lipids to prevent cardiovascular disease.

Authors:  Ngoc-Anh Le
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-08

2.  Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in type 2 diabetes.

Authors:  Anne Hiukka; Jamila Fruchart-Najib; Eeva Leinonen; Hannele Hilden; Jean-Charles Fruchart; Marja-Riitta Taskinen
Journal:  Diabetologia       Date:  2005-04-30       Impact factor: 10.122

Review 3.  The role of hypertriglyceridemia in atherosclerosis.

Authors:  Ngoc-Anh Le; Mary F Walter
Journal:  Curr Atheroscler Rep       Date:  2007-08       Impact factor: 5.113

Review 4.  Diabetic dyslipidaemia: from basic research to clinical practice.

Authors:  M-R Taskinen
Journal:  Diabetologia       Date:  2003-05-28       Impact factor: 10.122

5.  Myocardial metabolism of triacylglycerol-rich lipoproteins in type 2 diabetes.

Authors:  You-Guo Niu; Rhys D Evans
Journal:  J Physiol       Date:  2009-05-11       Impact factor: 5.182

6.  Very-low-density lipoprotein: complex particles in cardiac energy metabolism.

Authors:  You-Guo Niu; Rhys D Evans
Journal:  J Lipids       Date:  2011-07-03

7.  Is exercise a therapeutic tool for improvement of cardiovascular risk factors in adolescents with type 1 diabetes mellitus? A randomised controlled trial.

Authors:  Mona A Salem; Mohammed A AboElAsrar; Nancy S Elbarbary; Rana A ElHilaly; Yara M Refaat
Journal:  Diabetol Metab Syndr       Date:  2010-07-11       Impact factor: 3.320

Review 8.  Lipoprotein-associated oxidative stress: a new twist to the postprandial hypothesis.

Authors:  Ngoc-Anh Le
Journal:  Int J Mol Sci       Date:  2014-12-26       Impact factor: 5.923

Review 9.  Diabetes Dyslipidemia.

Authors:  Jonathan D Schofield; Yifen Liu; Prasanna Rao-Balakrishna; Rayaz A Malik; Handrean Soran
Journal:  Diabetes Ther       Date:  2016-04-07       Impact factor: 2.945

10.  Effect of exercise therapy on lipid profile and oxidative stress indicators in patients with type 2 diabetes.

Authors:  Lorenzo A Gordon; Errol Y Morrison; Donovan A McGrowder; Ronald Young; Yeiny Terry Pena Fraser; Eslaen Martorell Zamora; Ruby L Alexander-Lindo; Rachael R Irving
Journal:  BMC Complement Altern Med       Date:  2008-05-13       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.